Skip to main content
GemVax & KAEL Co.,Ltd. logo

GemVax & KAEL Co.,Ltd. — Investor Relations & Filings

Ticker · 082270 ISIN · KR7082270000 KO Manufacturing
Open in API
Filings indexed 647 across all filing types
Latest filing 2025-01-20 Director's Dealing
Country KR South Korea
Listing KO 082270

About GemVax & KAEL Co.,Ltd.

https://gemvax.com/

GemVax & KAEL is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics. Its lead drug candidate is GV1001, a synthetic peptide composed of 16 amino acids, which has demonstrated multiple actions including the modulation of neuroinflammation and reduction of oxidative stress. The company's development pipeline primarily targets neurodegenerative diseases, such as Alzheimer's disease and Progressive Supranuclear Palsy (PSP). Other therapeutic areas under investigation include pancreatic cancer and benign prostatic hyperplasia. GemVax & KAEL is actively advancing its programs through clinical trials to evaluate the efficacy and safety of its novel treatments.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. It details a change in share ownership by a major shareholder (Gem & Company) in GemVax & Kael. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) in the provided schema, as it reports insider/major shareholder transactions.
2025-01-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when a shareholder's stake changes significantly (often referred to as a 5% rule filing). It details the shareholding status, changes in ownership, and contractual relationships (such as pledges) of the major shareholder and their special related parties. Since this document type is a specific regulatory disclosure regarding share ownership thresholds and does not fit into other categories like 'Director's Dealing' (which is for individual insider trades) or 'Major Shareholding Notification' (which is the standard category for this type of filing), it is classified as a Major Shareholding Notification.
2025-01-20 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (GemVax) regarding a 'Correction Report' (정정신고) for a 'Stock Collateral Provision Agreement' (주식 담보제공 계약). This type of filing is a standard regulatory disclosure required when a major shareholder pledges shares as collateral for loans. It does not fit into categories like Annual Reports, Earnings Releases, or M&A. Since it is a specific regulatory disclosure regarding capital structure and collateral, it falls under the 'Regulatory Filings' category.
2025-01-20 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (GemVax) regarding a 'Correction Report' (정정신고) for a previously disclosed 'Stock Collateral Agreement' (최대주주 변경을 수반하는 주식 담보제공 계약 체결). It details changes to collateral terms, share counts, and loan extensions. This type of disclosure regarding financing, capital structure, and collateralization of shares by a major shareholder falls under the 'Capital/Financing Update' category.
2025-01-17 Korean
[기재정정]주요사항보고서(신주인수권부사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from GemVax & Kael, specifically detailing a correction (정정신고) to a previously filed decision to issue bonds with warrants (신주인수권부사채 발행결정). It outlines changes to the subscription list, exercise price, and total number of shares to be issued. This falls under capital structure changes and financing activities, which is classified as 'Capital/Financing Update' (CAP).
2025-01-07 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details changes in share ownership, including the addition of a special related party and the acquisition of call options on convertible bonds. This falls under the category of Major Shareholding Notification.
2025-01-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.